keyword
https://read.qxmd.com/read/38585027/biofluid-based-biomarkers-in-traumatic-brain-injury-a-narrative-review
#21
REVIEW
Da-Sol Kim, Gi-Wook Kim
Traumatic brain injury (TBI) is a complex condition characterized by a multifaceted pathophysiology. It presents significant diagnostic and prognostic challenges in clinical settings. This narrative review explores the evolving role of biofluid biomarkers as essential tools in the diagnosis, prognosis, and treatment of TBI. In recent times, preclinical and clinical trials utilizing these biofluid biomarkers have been actively pursued internationally. Among the biomarkers for nerve tissue proteins are neuronal biomarkers like neuronal specific enolase and ubiquitin C-terminal hydrolase L1; astroglia injury biomarkers such as S100B and glial fibrillary acidic protein; axonal injury and demyelination biomarkers, including neurofilaments and myelin basic protein; new axonal injury and neurodegeneration biomarkers like total tau and phosphorylated tau; and others such as spectrin breakdown products and microtubule-associated protein 2...
March 2024: Brain & NeuroRehabilitation
https://read.qxmd.com/read/38582621/pelizaeus-merzbacher-disease-on-the-cusp-of-myelin-medicine
#22
REVIEW
Matthew S Elitt, Paul J Tesar
Pelizaeus-Merzbacher disease (PMD) is caused by mutations in the proteolipid protein 1 (PLP1) gene encoding proteolipid protein (PLP). As a major component of myelin, mutated PLP causes progressive neurodegeneration and eventually death due to severe white matter deficits. Medical care has long been limited to symptomatic treatments, but first-in-class PMD therapies with novel mechanisms now stand poised to enter clinical trials. Here, we review PMD disease mechanisms and outline rationale for therapeutic interventions, including PLP1 suppression, cell transplantation, iron chelation, and intracellular stress modulation...
April 5, 2024: Trends in Molecular Medicine
https://read.qxmd.com/read/38582276/neuroprotective-effects-of-vce-004-8-in-a-rat-model-of-neonatal-stroke
#23
JOURNAL ARTICLE
María Villa, María Martínez-Vega, Laura Silva, Angela Romero, María de Hoz-Rivera, María Eugenia Prados, Eduardo Muñoz, José Martínez-Orgado
BACKGROUND: Currently there is no effective treatment for neonatal stroke, an acute neurologic syndrome with sequelae, due to focal ischemic, thrombotic, or hemorrhagic event occurring in the perinatal period. VCE-004.8, an aminoquinone exhibiting activity on CB2 and PPARγ receptors, is neuroprotective in adult mice models of acute and chronic brain damaging conditions. We hereby aimed to study VCE-004.8 neuroprotection in a rat model of neonatal stroke. METHODS: 7-day-old (P7) Wistar rats of both sexes were submitted to Middle Cerebral Artery Occlusion (MCAO), receiving i...
April 4, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38581130/a-study-concept-of-expeditious-clinical-enrollment-for-genetic-modifier-studies-in-charcot-marie-tooth-neuropathy-1a
#24
JOURNAL ARTICLE
Isaac R L Xu, Matt C Danzi, Ariel Ruiz, Jacquelyn Raposo, Yeisha Arcia De Jesus, Mary M Reilly, Andrea Cortese, Michael E Shy, Steven S Scherer, David N Herrmann, Vera Fridman, Jonathan Baets, Mario Saporta, Reza Seyedsadjadi, Tanya Stojkovic, Kristl G Claeys, Pooja Patel, Shawna Feely, Adriana P Rebelo, Maike F Dohrn, Stephan Züchner
BACKGROUND: Caused by duplications of the gene encoding peripheral myelin protein 22 (PMP22), Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common hereditary neuropathy. Despite this shared genetic origin, there is considerable variability in clinical severity. It is hypothesized that genetic modifiers contribute to this heterogeneity, the identification of which may reveal novel therapeutic targets. In this study, we present a comprehensive analysis of clinical examination results from 1564 CMT1A patients sourced from a prospective natural history study conducted by the RDCRN-INC (Inherited Neuropathy Consortium)...
April 5, 2024: Journal of the Peripheral Nervous System: JPNS
https://read.qxmd.com/read/38580905/the-relationship-between-serum-astroglial-and-neuronal-markers-and-aqp4-and-mog-autoantibodies
#25
JOURNAL ARTICLE
Miyo K Chatanaka, Lisa M Avery, Maria D Pasic, Shanthan Sithravadivel, Dalia Rotstein, Catherine Demos, Rachel Cohen, Taron Gorham, Mingyue Wang, Martin Stengelin, Anu Mathew, George Sigal, Jacob Wohlstadter, Ioannis Prassas, Eleftherios P Diamandis
BACKGROUND: Certain demyelinating disorders, such as neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) exhibit serum autoantibodies against aquaporin-4 (αAQP4) and myelin oligodendrocyte glycoprotein (αMOG). The variability of the autoantibody presentation warrants further research into subtyping each case. METHODS: To elucidate the relationship between astroglial and neuronal protein concentrations in the peripheral circulation with occurrence of these autoantibodies, 86 serum samples were analyzed using immunoassays...
April 5, 2024: Clinical Proteomics
https://read.qxmd.com/read/38576796/is-there-an-immunological-cross-reactivity-of-antibodies-to-the-myelin-oligodendrocyte-glycoprotein-and-coronaviruses
#26
JOURNAL ARTICLE
Kathrin Schanda, Sara Mariotto, Dagmar Rudzki, Angelika Bauer, Alessandro Dinoto, Patrizia Rossi, Sergio Ferrari, Sven Jarius, Brigitte Wildemann, Federica Boso, Bruno Giometto, Daniel Engels, Tania Kümpfel, Eva-Maria Wendel, Kevin Rostasy, Markus Reindl
Recent reports indicated that myelin oligodendrocyte glycoprotein antibody-associated disease might be a rare complication after severe acute respiratory syndrome coronavirus 2 infection or vaccination. It is unclear whether this is an unspecific sequel of infection or vaccination or caused by possible immunological cross-reactivity of severe acute respiratory syndrome coronavirus 2 proteins and myelin oligodendrocyte glycoprotein. The aim of this study was therefore to elucidate whether there is an immunological cross-reactivity between severe acute respiratory syndrome coronavirus 2 spike or nucleocapsid proteins and myelin oligodendrocyte glycoprotein and to explore the relation of antibody responses against myelin oligodendrocyte glycoprotein and severe acute respiratory syndrome coronavirus 2 and other coronaviruses...
2024: Brain communications
https://read.qxmd.com/read/38575092/spatial-omics-reveals-molecular-changes-in-focal-cortical-dysplasia-type-ii
#27
JOURNAL ARTICLE
Isabeau Vermeulen, Natalia Rodriguez-Alvarez, Liesbeth François, Delphine Viot, Fariba Poosti, Eleonora Aronica, Stefanie Dedeurwaerdere, Patrick Barton, Berta Cillero-Pastor, Ron M A Heeren
Focal cortical dysplasia (FCD) represents a group of diverse localized cortical lesions that are highly epileptogenic and occur due to abnormal brain development caused by genetic mutations, involving the mammalian target of rapamycin (mTOR). These somatic mutations lead to mosaicism in the affected brain, posing challenges to unravel the direct and indirect functional consequences of these mutations. To comprehensively characterize the impact of mTOR mutations on the brain, we employed here a multimodal approach in a preclinical mouse model of FCD type II (Rheb), focusing on spatial omics techniques to define the proteomic and lipidomic changes...
April 2, 2024: Neurobiology of Disease
https://read.qxmd.com/read/38570276/berberine-inhibits-nlrp3-inflammasome-activation-and-proinflammatory-macrophage-m1-polarization-to-accelerate-peripheral-nerve-regeneration
#28
JOURNAL ARTICLE
Jun Sun, Qiuhua Zeng, Zhimin Wu, Lixin Huang, Tao Sun, Cong Ling, Baoyu Zhang, Chuan Chen, Hui Wang
Berberine (BBR) has demonstrated potent anti-inflammatory effects by modulating macrophage polarization. Nevertheless, the precise mechanisms through which berberine regulates post-injury inflammation within the peripheral nerve system remain elusive. This study seeks to elucidate the role of BBR and its underlying mechanisms in inflammation following peripheral nerve injury (PNI). Adult male C57BL/6J mice subjected to PNI were administered daily doses of berberine (0, 60, 120, 180, 240 ​mg/kg) via gavage from day 1 through day 28...
April 2, 2024: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://read.qxmd.com/read/38566526/junctional-adhesion-molecule-a-deficient-mice-are-protected-from-severe-experimental-autoimmune-encephalomyelitis
#29
JOURNAL ARTICLE
Kristina Berve, Julia Michel, Silvia Tietz, Claudia Blatti, Daniela Ivan, Gaby Enzmann, Ruth Lyck, Urban Deutsch, Giuseppe Locatelli, Britta Engelhardt
In multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE), early pathological features include immune cell infiltration into the central nervous system (CNS) and blood-brain barrier (BBB) disruption. We investigated the role of junctional adhesion molecule-A (JAM-A), a tight junction protein, in active EAE (aEAE) pathogenesis. Our study confirms JAM-A expression at the blood-brain barrier and its luminal redistribution during aEAE. JAM-A deficient (JAM-A-/- ) C57BL/6J mice exhibited milder aEAE, unrelated to myelin oligodendrocyte glycoprotein-specific CD4+ T-cell priming...
April 2, 2024: European Journal of Immunology
https://read.qxmd.com/read/38564996/blood-sphingolipid-as-a-novel-biomarker-in-patients-with-neuromyelitis-optica-spectrum-disorder
#30
JOURNAL ARTICLE
Hyunjin Kim, Hwa Jung Kim, Jungmin So, Ji Yon Kim, Hee-Jae Jung, Seungmi Kim, Dayoung Seo, Hyun-Ji Kim, Ha Eun Song, Young-Min Lim, Hyun Ju Yoo, Eun-Jae Lee
BACKGROUND: Sphingolipids are signaling molecules and structural components of the axolemma and myelin sheath. Plasma sphingolipid levels may reflect disease status of neuromyelitis optica spectrum disorder (NMOSD). We aimed to examine plasma sphingolipids as disease severity biomarkers for NMOSD and compare their characteristics with those of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP). METHODS: We measured plasma sphingolipids, sNfL, and sGFAP levels in NMOSD cases with anti-aquaporin-4-antibody...
March 20, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38562812/loss-of-prohibitin-2-in-schwann-cells-dysregulates-key-transcription-factors-controlling-developmental-myelination
#31
Emma R Wilson, Gustavo Della-Flora Nunes, Shichen Shen, Seth Moore, Joseph Gawron, Jessica Maxwell, Umair Syed, Edward Hurley, Meghana Lanka, Jun Qu, Laurent Desaubry, Lawrence Wrabetz, Yannick Poitelon, M Laura Feltri
Schwann cells are critical for the proper development and function of the peripheral nervous system, where they form a mutually beneficial relationship with axons. Past studies have highlighted that a pair of proteins called the prohibitins play major roles in Schwann cell biology. Prohibitins are ubiquitously expressed and versatile proteins. We have previously shown that while prohibitins play a crucial role in Schwann cell mitochondria for long-term myelin maintenance and axon health, they may also be present at the Schwann cell-axon interface during development...
March 20, 2024: bioRxiv
https://read.qxmd.com/read/38561452/clinical-phenotype-and-genetic-function-analysis-of-a-family-with-hypomyelinating-leukodystrophy-7-caused-by-polr3a-mutation
#32
JOURNAL ARTICLE
Dan-Dan Ruan, Xing-Lin Ruan, Ruo-Li Wang, Xin-Fu Lin, Yan-Ping Zhang, Bin Lin, Shi-Jie Li, Min Wu, Qian Chen, Jian-Hui Zhang, Qiong Cheng, Yi-Wu Zhang, Fan Lin, Jie-Wei Luo, Zheng Zheng, Yun-Fei Li
Hypomyelinating leukodystrophy (HLD) is a rare genetic heterogeneous disease that can affect myelin development in the central nervous system. This study aims to analyze the clinical phenotype and genetic function of a family with HLD-7 caused by POLR3A mutation. The proband (IV6) in this family mainly showed progressive cognitive decline, dentin dysplasia, and hypogonadotropic hypogonadism. Her three old brothers (IV1, IV2, and IV4) also had different degrees of ataxia, dystonia, or dysarthria besides the aforementioned manifestations...
April 1, 2024: Scientific Reports
https://read.qxmd.com/read/38558977/lesion-remote-astrocytes-govern-microglia-mediated-white-matter-repair
#33
Sarah McCallum, Keshav B Suresh, Timothy Islam, Ann W Saustad, Oksana Shelest, Aditya Patil, David Lee, Brandon Kwon, Inga Yenokian, Riki Kawaguchi, Connor H Beveridge, Palak Manchandra, Caitlin E Randolph, Gordon P Meares, Ranjan Dutta, Jasmine Plummer, Simon R V Knott, Gaurav Chopra, Joshua E Burda
Spared regions of the damaged central nervous system undergo dynamic remodeling and exhibit a remarkable potential for therapeutic exploitation. Here, lesion-remote astrocytes (LRAs), which interact with viable neurons, glia and neural circuitry, undergo reactive transformations whose molecular and functional properties are poorly understood. Using multiple transcriptional profiling methods, we interrogated LRAs from spared regions of mouse spinal cord following traumatic spinal cord injury (SCI). We show that LRAs acquire a spectrum of molecularly distinct, neuroanatomically restricted reactivity states that evolve after SCI...
March 17, 2024: bioRxiv
https://read.qxmd.com/read/38556884/foxo1-reshapes-neutrophils-to-aggravate-acute-brain-damage-and-promote-late-depression-after-traumatic-brain-injury
#34
JOURNAL ARTICLE
Mi Zhou, Yang-Wu-Yue Liu, Yu-Hang He, Jing-Yu Zhang, Hao Guo, Hao Wang, Jia-Kui Ren, Yi-Xun Su, Teng Yang, Jia-Bo Li, Wen-Hui He, Peng-Jiao Ma, Man-Tian Mi, Shuang-Shuang Dai
BACKGROUND: Neutrophils are traditionally viewed as first responders but have a short onset of action in response to traumatic brain injury (TBI). However, the heterogeneity, multifunctionality, and time-dependent modulation of brain damage and outcome mediated by neutrophils after TBI remain poorly understood. METHODS: Using the combined single-cell transcriptomics, metabolomics, and proteomics analysis from TBI patients and the TBI mouse model, we investigate a novel neutrophil phenotype and its associated effects on TBI outcome by neurological deficit scoring and behavioral tests...
March 31, 2024: Military Medical Research
https://read.qxmd.com/read/38556574/microglial-phagolysosome-dysfunction-and-altered-neural-communication-amplify-phenotypic-severity-in-prader-willi-syndrome-with-larger-deletion
#35
JOURNAL ARTICLE
Felipe Correa-da-Silva, Jenny Carter, Xin-Yuan Wang, Rui Sun, Ekta Pathak, José Manuel Monroy Kuhn, Sonja C Schriever, Clarissa M Maya-Monteiro, Han Jiao, Martin J Kalsbeek, Pedro M M Moraes-Vieira, Johan J P Gille, Margje Sinnema, Constance T R M Stumpel, Leopold M G Curfs, Dirk Jan Stenvers, Paul T Pfluger, Dominik Lutter, Alberto M Pereira, Andries Kalsbeek, Eric Fliers, Dick F Swaab, Lawrence Wilkinson, Yuanqing Gao, Chun-Xia Yi
Prader-Willi Syndrome (PWS) is a rare neurodevelopmental disorder of genetic etiology, characterized by paternal deletion of genes located at chromosome 15 in 70% of cases. Two distinct genetic subtypes of PWS deletions are characterized, where type I (PWS T1) carries four extra haploinsufficient genes compared to type II (PWS T2). PWS T1 individuals display more pronounced physiological and cognitive abnormalities than PWS T2, yet the exact neuropathological mechanisms behind these differences remain unclear...
March 31, 2024: Acta Neuropathologica
https://read.qxmd.com/read/38556140/buyang-huanwu-decoction-promotes-remyelination-via-mir-760-3p-gpr17-axis-after-intracerebral-hemorrhage
#36
JOURNAL ARTICLE
Yang Wang, Zhe Yu, Menghan Cheng, En Hu, Qiuju Yan, Fei Zheng, Xiaohang Guo, Wei Zhang, Haigang Li, Zhilin Li, Wenxin Zhu, Yao Wu, Tao Tang, Teng Li
ETHNOPHARMACOLOGICAL RELEVANCE: The repairment of myelin sheaths is crucial for mitigating neurological impairments of intracerebral hemorrhage (ICH). However, the current research on remyelination processes in ICH remains limited. A representative traditional Chinese medicine, Buyang Huanwu decoction (BYHWD), shows a promising therapeutic strategy for ICH treatment. AIM OF THE STUDY: To investigate the pro-remyelination effects of BYHWD on ICH and explore the underlying mechanisms...
March 29, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38550390/transcriptomic-analysis-of-gene-expression-and-effect-of-electromagnetic-field-in-brain-tissue-after-traumatic-brain-injury
#37
JOURNAL ARTICLE
Vikrant Rai, Yssel Mendoza-Mari, James Brazdzionis, Mohamed M Radwan, David A Connett, Dan E Miulli, Devendra K Agrawal
Traumatic brain injury (TBI) due to a direct blow or penetrating injury to the head damages the brain tissue and affects brain function. Primary and secondary damage to the brain tissue increases disability, morbidity, and mortality and costs millions of dollars in treatment. Injury to the brain tissue results in the activation of various inflammatory and repair pathways involving many cellular and molecular factors. Increased infiltration of immune cells to clear the debris and lesion healing, activation of Schwann cells, myelination, oligodendrocyte formation, and axonal regeneration occur after TBI to regenerate the tissue...
2024: J Biotechnol Biomed
https://read.qxmd.com/read/38549375/evaluation-of-safety-and-early-efficacy-of-aav-gene-therapy-in-mouse-models-of-vanishing-white-matter-disease
#38
JOURNAL ARTICLE
Jessica A Herstine, Pi-Kai Chang, Sergiy Chornyy, Tamara J Stevenson, Alex C Sunshine, Ksenia Nokhrina, Jessica Rediger, Julia Wentz, Tatyana A Vetter, Erika Scholl, Caleb Holaway, Nettie K Pyne, Anna Bratasz, Stewart Yeoh, Kevin M Flanigan, Joshua L Bonkowsky, Allison M Bradbury
Leukoencephalopathy with Vanishing White Matter (VWM) is a progressive incurable white matter disease that most commonly occurs in childhood and presents with ataxia, spasticity, neurological degeneration, seizures, and premature death. A distinctive feature is episodes of rapid neurological deterioration provoked by stressors such as infection, seizures, or trauma. VWM is caused by autosomal recessive mutations in one of five genes that encode the Eukaryotic Initiation Factor 2B complex, which is necessary for protein translation and regulation of the integrated stress response...
March 27, 2024: Molecular Therapy
https://read.qxmd.com/read/38546197/the-myelination-associated-g-protein-coupled-receptor-37-is-regulated-by-zfp488-nkx2-2-and-sox10-during-oligodendrocyte-differentiation
#39
JOURNAL ARTICLE
Antonia L Schmidt, Marco Kremp, Takaaki Aratake, Siying Cui, Yifeng Lin, Xiaowen Zhong, Q Richard Lu, Chengfu Zhang, Mengsheng Qiu, Tim Aberle, Michael Wegner
Oligodendrocyte differentiation and myelination in the central nervous system are controlled and coordinated by a complex gene regulatory network that contains several transcription factors, including Zfp488 and Nkx2.2. Despite the proven role in oligodendrocyte differentiation little is known about the exact mode of Zfp488 and Nkx2.2 action, including their target genes. Here, we used overexpression of Zfp488 and Nkx2.2 in differentiating CG4 cells to identify aspects of the oligodendroglial expression profile that depend on these transcription factors...
March 28, 2024: Glia
https://read.qxmd.com/read/38544400/congenital-spongiform-leukodystrophy-in-2-female-littermate-german-shepherd-puppies
#40
Ricardo De Miguel, Devon Wallis Hague, Jennifer L Johnson, Amber M Zilinger, Anna Kukekova, Stephane Lezmi
Two 9-week-old female littermate German Shepherd puppies showed severe high-frequency low-amplitude trembling that worsened with movement. The white matter (WM) of the central nervous system (CNS) showed bilateral diffuse severe spongiosis in the cerebellum, brainstem, spinal cord, and the neuropil of the oculomotor and red nuclei. The cortical corona radiata was less severely affected. Rare necrotic or apoptotic glia-like cells also were identified in the WM. Luxol fast blue staining disclosed severe diffuse myelin loss in the entire CNS; peripheral nerves were spared...
March 27, 2024: Journal of Veterinary Internal Medicine
keyword
keyword
61418
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.